Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Remote monitoring of inhaled bronchodilator use and weekly feedback about asthma management: an open-group, short-term pilot study of the impact on asthma control.

Van Sickle D, Magzamen S, Truelove S, Morrison T.

PLoS One. 2013;8(2):e55335. doi: 10.1371/journal.pone.0055335. Epub 2013 Feb 27.

3.

Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.

van der Molen T, Postma DS, Turner MO, Jong BM, Malo JL, Chapman K, Grossman R, de Graaff CS, Riemersma RA, Sears MR.

Thorax. 1997 Jun;52(6):535-9.

5.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
6.

Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.

Vogelmeier C, Naya I, Ekelund J.

Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.

PMID:
22607479
7.

Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study.

van der Meer V, van Stel HF, Bakker MJ, Roldaan AC, Assendelft WJ, Sterk PJ, Rabe KF, Sont JK; SMASHING (Self-Management of Asthma Supported by Hospitals, ICT, Nurses and General practitioners) Study Group..

Respir Res. 2010 Jun 10;11:74. doi: 10.1186/1465-9921-11-74.

9.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
10.
11.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
12.

Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence.

Onyirimba F, Apter A, Reisine S, Litt M, McCusker C, Connors M, ZuWallack R.

Ann Allergy Asthma Immunol. 2003 Apr;90(4):411-5.

PMID:
12722963
13.

Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.

Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B.

Pediatrics. 2003 Sep;112(3 Pt 1):e212-9.

PMID:
12949315
14.

Which patients are prescribed inhaled anti-asthma drugs?

Roberts SJ, Bateman DN.

Thorax. 1994 Nov;49(11):1090-5.

15.

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.

Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.

Curr Med Res Opin. 2004 Sep;20(9):1403-18.

PMID:
15383189
16.

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.

PMID:
16235410
17.

Changes in asthmatic patients' symptoms and lifestyles on institution of inhaled budesonide therapy.

Nankani JN, Northfield M, Beran YM, Richardson PD.

Curr Med Res Opin. 1990;12(3):198-206.

PMID:
2272194
18.

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harré E, Laubscher K, Linscott V, Ramsay CM, Richards G.

Thorax. 1998 Sep;53(9):744-52. Erratum in: Thorax 1999 Feb;54(2):188.

19.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

20.

Optimal asthma control, starting with high doses of inhaled budesonide.

Reddel HK, Jenkins CR, Marks GB, Ware SI, Xuan W, Salome CM, Badcock CA, Woolcock AJ.

Eur Respir J. 2000 Aug;16(2):226-35. Erratum in: Eur Respir J 2000 Sep;16(3):579.

Supplemental Content

Support Center